FDA Approves First Vaccine Against RSV in Neonates, Babies up to Age 24 Months
Nirsevimab won unanimous support from the FDA AMDAC on the vaccine's positive benefit/risk profile to prevent RSV in newborns and infants in their first RSV season.
For the Statin-Intolerant or Statin-Unwilling Patient, Part 2: Other Pharmaceutical Options
For the 1 in 3 individuals with hyperlipidemia who can't or won't take a statin, preventive cardiologist Elizabeth Klodas, MD, details 3 alternative drug classes.
New Research Suggests Preoperative High-intensity Interval Training is Beneficial for Cardiorespiratory Health
Findings from meta-analysis showed preoperative high-intensity interval training was associated with improvements in exercise capacity and a reduction in postoperative complications.
Long COVID in Older Adults: Be Alert for These Signs, says Physiatrist Talya Fleming, MD
Primary care clinicians will need to be particularly alert for signs of long COVID in older patients as some signs and symptoms may be easily attributed to the aging process.
Daily Dose: Association of Racial Discrimination with Adiposity in Children
Your daily dose of clinical news you may have missed.
Less than Half of Patients with New AF Diagnosis Prescribed Oral Anticoagulation within 6 Months
Factors positively associated with a timely first OAC Rx among the 41.3% who received one included male sex, certain comorbidities, other current medications, and obesity.
FDA Approves Nirsevimab-alip Injection to Prevent RSV in Neonates, Infants
FDA approval of the monoclonal antibody against RSV follows the unanimous vote from the agency's Antimicrobial Drugs Advisory Committee.
When Statins Are Not an Option, Part 1: Leverage Nutrition First
Preventive cardiologist Elizabeth Klodas, MD, reviews the essential elements of a plan of eating shown clinically to reduce hyperlipidemia.
The Potential Impact of Lecenemab on Current, Future Treatment of Alzheimer Disease: Expert Interview
Howard Fillit, MD, cofounder/chief scientific officer of the Alzheimer Drug Discovery Foundation, says lecenumab's approval opens the door for future drug development.
CDC's Fall "Bridge Access Program" to Provide Free COVID-19 Vaccines, Treatment to Uninsured, Underinsured US Adults
For the 25-30 million uninsured adults in the US, the program, which will end in December 2024, will ensure access to protection from the virus for another year.
Daily Dose: T2D Raises Risk for Hepatic Decompensation, Hepatocellular Carcinoma in Patients with NAFLD
Flu Vaccination for Children May Reduce Hospitalization for RSV, Suggest New Data
The influenza vaccine may offer a protective effect against hospitalization for respiratory syncytial virus in young children, suggest data from Australia.
BMI vs body fat; menopause and martinis; statin guidelines collide; +2 - The Five for Friday
Is BMI or body fat a better estimate of obesity?; spoiler: older women do drink ETOH; USPSTF vs ACC/AHA; plus no more opioids for LBP and a primer on migraine meds.
FDA Approves First Over-the-Counter Daily Oral Contraceptive Pill
The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.
Daily Dose: Trends in Body Weight Perception Among Adolescents
Back Pain on Eliquis: Seen in the ED
The 72-year-old woman says the back pain came on earlier in the evening without injury or heavy lifting and radiates slightly to her left leg. What does the MRI show?
Racial Discrimination may be Risk Factor for Obesity in Children, Suggests New Research
Children and adolescents who reported facing more racial discrimination had a higher BMI and waist circumference, according to new data.
The BMI vs Body Fat Debate: Study Suggests One-Third of People with Normal BMI are Obese
In Israel, where 60% of adults are overweight, new research prompts investigators to suggest that % body fat should replace BMI as the gold standard measure of obesity.
Daily Dose: Opioid Use for Low Back Pain and Neck Pain
Primary Care Management of Headache: Part 1
An overview of common headache conditions and treatments for primary care clinicians, here.
